Table 4:
Univariable and multivariable Cox proportional hazard models for any failure after CMR on early post-treatment FDG-PET.
| Baseline factors | Univariable HR (95% CI) | P value | Multivariable HR (95% CI) | P value |
|---|---|---|---|---|
| Age | 0.99 (0.98–1.01) | 0.40 | ||
| T stage | ||||
| I-II | Ref | Ref | ||
| III-IVA | 2.16 (1.46–3.22) | <0.001 | 2.09 (1.40–3.11) | <0.001 |
| MTV* | 1.00 (0.99–1.01) | 0.94 | ||
| Cervix SUVmax** | 1.00 (0.97–1.02) | 0.70 | ||
| PET lymph nodes | ||||
| None | Ref | Ref | ||
| Pelvic | 1.28 (0.85–1.93) | 0.24 | 1.29 (0.86–1.95) | 0.22 |
| Pelvic and PA | 2.21 (1.28–3.83) | 0.005 | 2.03 (1.17–3.52) | 0.01 |
| Histology | ||||
| Squamous | Ref | |||
| Non-squamous | 1.04 (0.61–1.76) | 0.90 | ||
| Brachytherapy | ||||
| HDR | Ref | |||
| LDR | 0.67 (0.36–1.23) | 0.20 | ||
| EBRT planning | ||||
| IMRT | Ref | |||
| 2D EBRT | 1.29 (0.87–1.90) | 0.21 | ||
| Treatment length | 1.03 (1.005–1.05) | 0.01 | NS, removed from model |